EUR 0.08
(-1.89%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 802 Thousand EUR | 131.03% |
2022 | -2.58 Million EUR | 77.51% |
2021 | -11.49 Million EUR | -483.16% |
2020 | -1.97 Million EUR | -196.71% |
2019 | 2.03 Million EUR | -50.16% |
2018 | 4.08 Million EUR | 33.15% |
2017 | 3.07 Million EUR | 15.35% |
2016 | 2.66 Million EUR | -51.82% |
2015 | 5.52 Million EUR | -24.61% |
2014 | 7.32 Million EUR | 1095.18% |
2013 | 613.26 Thousand EUR | -73.0% |
2012 | 2.27 Million EUR | 42.43% |
2011 | 1.59 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 244 Thousand EUR | 0.0% |
2023 Q2 | -553 Thousand EUR | 0.0% |
2023 FY | 802 Thousand EUR | 131.03% |
2023 Q4 | 802 Thousand EUR | 0.0% |
2022 Q4 | -2.58 Million EUR | 0.0% |
2022 Q2 | -10.83 Million EUR | 0.0% |
2022 FY | -2.58 Million EUR | 77.51% |
2021 Q2 | -11.57 Million EUR | 0.0% |
2021 FY | -11.49 Million EUR | -483.16% |
2021 Q4 | -11.49 Million EUR | 0.0% |
2020 Q4 | -1.97 Million EUR | 0.0% |
2020 FY | -1.97 Million EUR | -196.71% |
2020 Q2 | 492 Thousand EUR | 0.0% |
2019 Q2 | 3.48 Million EUR | 0.0% |
2019 FY | 2.03 Million EUR | -50.16% |
2019 Q4 | 2.03 Million EUR | 0.0% |
2018 Q2 | 5.08 Million EUR | 0.0% |
2018 Q4 | 3.77 Million EUR | 0.0% |
2018 FY | 4.08 Million EUR | 33.15% |
2017 Q4 | 2.67 Million EUR | 0.0% |
2017 FY | 3.07 Million EUR | 15.35% |
2017 Q2 | 4.36 Million EUR | 0.0% |
2016 Q2 | 3.58 Million EUR | 0.0% |
2016 FY | 2.66 Million EUR | -51.82% |
2016 Q4 | 2.67 Million EUR | 0.0% |
2015 Q2 | 2.94 Million EUR | 0.0% |
2015 FY | 5.52 Million EUR | -24.61% |
2015 Q4 | 5.52 Million EUR | 0.0% |
2014 FY | 7.32 Million EUR | 1095.18% |
2014 Q4 | 7.32 Million EUR | 0.0% |
2014 Q2 | 2.2 Million EUR | 0.0% |
2013 FY | 613.26 Thousand EUR | -73.0% |
2013 Q4 | 613.26 Thousand EUR | 0.0% |
2013 Q2 | -869.79 Thousand EUR | 0.0% |
2012 FY | 2.27 Million EUR | 42.43% |
2012 Q4 | 2.27 Million EUR | 0.0% |
2011 FY | 1.59 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Crossject Société Anonyme | 13.88 Million EUR | 94.224% |
Safe Orthopaedics SA | 9.13 Million EUR | 91.217% |
Amplitude Surgical SA | 78.54 Million EUR | 98.979% |
Sartorius Stedim Biotech S.A. | 3.56 Billion EUR | 99.978% |
EssilorLuxottica Société anonyme | 9.09 Billion EUR | 99.991% |
bonyf N.V. | 65.04 Thousand EUR | -1133.068% |